{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:04:03Z","timestamp":1791576243755,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejim.2023.10.010","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T11:23:29Z","timestamp":1698060209000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Anticoagulation in atrial fibrillation. A large real-world update"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-0243","authenticated-orcid":false,"given":"Mario","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-3875","authenticated-orcid":false,"given":"Stefano","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-8936","authenticated-orcid":false,"given":"Paolo","family":"Verdecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-0702","authenticated-orcid":false,"given":"Gianpaolo","family":"Reboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Boccanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.10.010_bib0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.10.010_bib0002","doi-asserted-by":"crossref","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2023.10.010_bib0003","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2023.10.010_bib0004","doi-asserted-by":"crossref","first-page":"k2505","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2023.10.010_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ehjcvp\/pvz086","article-title":"Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study","volume":"6","author":"Rutherford","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ejim.2023.10.010_bib0006","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2023.10.010_bib0007","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.10.010_bib0008","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2023.10.010_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.04.023","article-title":"Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations","volume":"101","author":"Imberti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0010","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/euac123","volume":"25","author":"Savelieva","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2023.10.010_bib0011","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/jgs.17884","article-title":"Oral anticoagulants and outcomes in adults >\/=80 years with atrial fibrillation: a global federated health network analysis","volume":"70","author":"Harrison","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2023.10.010_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2019.10.026","article-title":"Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillation","volume":"71","author":"Bo","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0013","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/jgs.15058","article-title":"Effect of new oral anticoagulants on prescribing practices for atrial fibrillation in older adults","volume":"65","author":"Fohtung","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2023.10.010_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cjca.2021.09.021","article-title":"The introduction of direct oral anticoagulants has not resolved treatment gaps for frail patients with nonvalvular atrial fibrillation","volume":"38","author":"Orlandi","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2023.10.010_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jgs.16822","article-title":"Geriatric syndromes and atrial fibrillation: prevalence and association with anticoagulant use in a national cohort of older Americans","volume":"69","author":"Shah","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2023.10.010_bib0016","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/europace\/eux288","article-title":"Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey","volume":"19","author":"Fumagalli","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2023.10.010_bib0017","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjcard.2015.11.032","article-title":"Effects of oral anticoagulant therapy in medical inpatients >\/=65 years with atrial fibrillation","volume":"117","author":"Bo","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2023.10.010_bib0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0019","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2023.10.010_bib0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2023.10.010_bib0021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejim.2023.10.010_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejim.2022.01.014","article-title":"Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: differences in the questions to be answered","volume":"99","author":"Rubboli","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0023","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1160\/TH16-05-0403","article-title":"Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis","volume":"116","author":"Lip","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2023.10.010_bib0024","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","author":"Grymonprez","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2023.10.010_bib0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/STROKEAHA.121.036757","article-title":"Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation","volume":"53","author":"Kim","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2023.10.010_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007971","article-title":"Off-label under- and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis","volume":"14","author":"Zhang","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2023.10.010_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ehjcvp\/pvaa103","article-title":"Off-label use of reduced dose direct oral factor Xa inhibitors in subjects with atrial fibrillation: a review of clinical evidence","volume":"7","author":"Bo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ejim.2023.10.010_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2021.04.013","article-title":"Patients with atrial fibrillation receiving NOACs: the boundary between appropriate and inappropriate dose","volume":"88","author":"Vedovati","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0029","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/europace\/euac004","article-title":"Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis","volume":"24","author":"Diemberger","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2023.10.010_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2021.01.006","article-title":"Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology","volume":"86","author":"Boriani","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.10.010_bib0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/VHRM.S162004","volume":"14","author":"Degli Esposti","year":"2018","journal-title":"Vasc Health Risk Manag"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:57:23Z","timestamp":1737604643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S0953620523003655"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.10.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation in atrial fibrillation. A large real-world update","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}